Home » ANGIOTECH BUYS QUILL FOR $40M
ANGIOTECH BUYS QUILL FOR $40M
Angiotech Pharmaceuticals Inc. has agreed to buy private aesthetic surgery and wound closure technology firm Quill Medical Inc. for at least $40 million US in cash.
The Globe and Mail
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May